Table 1.
Sensitivity analysis of the causal association between IBD and kidney function
Exposure | Outcomes | Cochran Q test | MR–Egger | MR–PRESSO | ||
---|---|---|---|---|---|---|
Q value | P | Intercept | P | P value | ||
UC | eGFRcrea | 98.03 | 0.022 | −0.0002 | 0.09 | 0.26 |
uACR | 101.31 | 0.019 | 0.0004 | 0.62 | 0.002 | |
Urolithiasis | 105.59 | 0.011 | −0.004 | 0.54 | 0.79 | |
IgA nephropathy | 84.62 | 0.26 | −4.49 × 10–6 | 0.99 | 0.43 | |
CKD | 112.62 | 0.0078 | 0.0003 | 0.92 | 0.64 | |
CD | eGFRcrea | 198.16 | 9.31 × 10–10 | −3.86 × 10–5 | 0.81 | 0.70 |
uACR | 194.11 | 2.63 × 10–8 | 4.7 × 10–5 | 0.96 | 0.19 | |
Urolithiasis | 161.52 | 0.0001 | 0.0046 | 0.48 | 0.019 | |
IgA nephropathy | 116.99 | 0.164 | 0.0022 | 0.57 | 0.83 | |
CKD | 146.29 | 0.0048 | 0.0017 | 0.61 | 0.06 |